Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi's Labs rallies to 2-year high on healthy Q4 results

** Shares of Divi's Laboratories  DIVI.NS  rise 5.7% to
two-year high of 4,359 rupees, rallying for 6th session in a row
    ** DIVI's top gainer on benchmark Nifty 50  .NSEI  and
pharma index  .NIPHARM 
    ** Co's Q4 consol net profit rose ~68% Y/Y on strong demand
    ** Motilal Oswal expects DIVI to gain market share and
maintain profitability in active pharmaceutical ingredients
(API) portfolio
    ** Prabhudas Lilladher says gross margins stabilized, likely
to improve on better product mix and stable raw material prices
    ** Trading vol is over 4x the 30-day avg, busiest day in a
year
    ** DIVI up 10% YTD, more than the Nifty 50 (~6%), but less
than pharma index (~14%)

 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))

Recent news on Divi's Laboratories

See all news